Holen Sie sich die Stockscreener-App
15.33
2.34%
0.35
Schlusskurs vom Vortag:
$14.98
Offen:
$15.09
24-Stunden-Volumen:
321.15K
Relative Volume:
0.57
Marktkapitalisierung:
$665.19M
Einnahmen:
$150.71M
Nettoeinkommen (Verlust:
$-40.85M
KGV:
-15.18
EPS:
-1.01
Netto-Cashflow:
$-25.98M
1W Leistung:
-1.67%
1M Leistung:
-14.26%
6M Leistung:
-2.36%
1J Leistung:
-6.52%
1-Tages-Spanne:
$15.04
$15.52
1-Wochen-Bereich:
$14.75
$15.81
52-Wochen-Spanne:
$12.49
$21.89
Si Bone Inc Stock (SIBN) Company Profile
Firmenname
Si Bone Inc
Sektor
Branche
Telefon
(408) 207-0700
Adresse
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
15.33 | 650.00M | 150.71M | -40.85M | -25.98M | -1.01 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-06-08 | Eingeleitet | Citigroup | Buy |
| 2021-03-09 | Bestätigt | Needham | Buy |
| 2020-12-16 | Bestätigt | Needham | Buy |
| 2020-08-04 | Bestätigt | Needham | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-05 | Bestätigt | Needham | Buy |
| 2020-02-19 | Eingeleitet | Needham | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-11-12 | Eingeleitet | BofA/Merrill | Buy |
| 2018-11-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-11-12 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-11-12 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Si Bone Inc Aktie (SIBN) Neueste Nachrichten
Is SI BONE Inc. stock a buy before product launches2025 Major Catalysts & Advanced Swing Trade Entry Plans - mfd.ru
SI-BONE, Inc. (SIBN) Stock Analysis: A 69.56% Potential Upside Amid Strong Buy Ratings - DirectorsTalk Interviews
Impax Asset Management Group plc Increases Stake in SiBone $SIBN - MarketBeat
How higher bond yields impact SI BONE Inc. (2K3) stock2025 Major Catalysts & Free Real-Time Volume Trigger Notifications - mfd.ru
How does SI BONE Inc. compare to its peersJuly 2025 Snapshot & Verified Swing Trading Watchlist - mfd.ru
More Unpleasant Surprises Could Be In Store For SI-BONE, Inc.'s (NASDAQ:SIBN) Shares After Tumbling 27% - 富途牛牛
Avoiding Lag: Real-Time Signals in (SIBN) Movement - Stock Traders Daily
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026 - The Manila Times
SI-BONE, Inc. to Announce Q4 and Full Year 2025 Financial Results on February 23, 2026 - Quiver Quantitative
Y Intercept Hong Kong Ltd Grows Stake in SiBone $SIBN - MarketBeat
SiBone (NASDAQ:SIBN) Upgraded by TD Cowen to Strong-Buy Rating - MarketBeat
Breakout Watch: What is the next catalyst for SI BONE IncTrade Analysis Report & Intraday High Probability Alerts - baoquankhu1.vn
TD Cowen Initiates Coverage on SI-BONE (SIBN) with a 'Buy' Ratin - GuruFocus
A Glimpse Into The Expert Outlook On SI-BONE Through 5 Analysts - Benzinga
TD Cowen Initiates Coverage on SI-BONE With Buy Rating, $21 Price Target - marketscreener.com
TD Cowen initiates coverage on SI-BONE stock with Buy rating - Investing.com
Discipline and Rules-Based Execution in SIBN Response - Stock Traders Daily
SI-BONE, Inc. (SIBN) Stock Analysis: A 53% Upside Potential as Analysts Strongly Favor a Buy - DirectorsTalk Interviews
SiBone (NASDAQ:SIBN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
SiBone (NASDAQ:SIBN) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Financial Review: SiBone (NASDAQ:SIBN) vs. Adagio Medical (NASDAQ:ADGM) - Defense World
Jim Cramer on SI-BONE: "This is a great, great speculation" - MSN
Momentum Shift: Will SI BONE Inc benefit from rising consumer demandInsider Selling & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Take Profit: Whats the outlook for Bausch Health Companies Incs sectorMarket Activity Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
ETF Watch: Can SI BONE Inc be recession proofStock Surge & Verified Momentum Stock Ideas - baoquankhu1.vn
Further Weakness as SI-BONE (NASDAQ:SIBN) Drops 12% This Week, Taking Five-year Losses to 39% - 富途资讯
Behavioral Patterns of SIBN and Institutional Flows - Stock Traders Daily
New Highs: Can SI BONE Inc stock weather global recessionJuly 2025 Snapshot & Verified Momentum Stock Watchlist - Bộ Nội Vụ
Aug Intraday: Can SI BONE Inc stock hit record highs againM&A Rumor & Risk Adjusted Buy and Sell Alerts - Bộ Nội Vụ
Stock Market Recap: Is SI BONE Inc. (2K3) stock a top hedge fund pickEarnings Risk Summary & Detailed Earnings Play Strategies - Bộ Nội Vụ
US-based SI-BONE’s preliminary revenue up 15% in Q4 2025 - Medical Buyer
Returns Recap: Will SI BONE Inc stock see PE expansionPortfolio Gains Report & Smart Swing Trading Alerts - Bộ Nội Vụ
SiBone (NASDAQ:SIBN) Director Jeffrey Dunn Sells 20,000 Shares of Stock - Defense World
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), SI-Bone (SIBN) and Guardant Health (GH) - The Globe and Mail
SiBone (NASDAQ:SIBN) Director Jeffrey Dunn Sells 20,000 Shares - MarketBeat
Dunn (SI-Bone director) sells $425k in SIBN stock By Investing.com - Investing.com Nigeria
Dunn (SI-Bone director) sells $425k in SIBN stock - Investing.com
SiBone (NASDAQ:SIBN) Shares Down 6.7%Here's Why - MarketBeat
Press Release: SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 - 富途资讯
SIBN Reports Strong Preliminary Q4 U.S. Revenue Growth - GuruFocus
SI-BONE Reports Strong Preliminary Q4 and 2025 Revenue Growth - TipRanks
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 - The Manila Times
SI-BONE, Inc. Reports Preliminary Fourth Quarter and Full Year 2025 Revenue Growth | SIBN Stock News - Quiver Quantitative
Aug Movers: Can SI BONE Inc weather a recession2025 Trading Recap & Smart Investment Allocation Insights - baoquankhu1.vn
Assessing SI-BONE (SIBN) Valuation After Jim Cramer Endorsements And New Analyst Coverage - Yahoo Finance
SI-BONE Q4 2026 Earnings Preview: Recent $SIBN Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Does Cramer’s ‘Great, Great Speculation’ Tag Alter SI-BONE’s Risk Narrative and Niche Thesis (SIBN)? - Yahoo Finance
Lobbying Update: $10,000 of SI-BONE INC. lobbying was just disclosed | SIBN Stock News - Quiver Quantitative
EPS Watch: Why SI BONE Inc 2K3 stock attracts HNW investors2025 Biggest Moves & Low Drawdown Trading Techniques - moha.gov.vn
Jim Cramer on SI-BONE: "This is a Great, Great Speculation" - Finviz
Jim Cramer on SI-BONE: “This is a Great, Great Speculation” - Insider Monkey
Finanzdaten der Si Bone Inc-Aktie (SIBN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Si Bone Inc-Aktie (SIBN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DUNN JEFFREY W | Director |
Jan 08 '26 |
Sale |
21.28 |
20,000 |
425,506 |
80,115 |
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):